Screening for antibodies in narcolepsy type 1 and type 2

Screening for antibodies in narcolepsy type 1 and type 2

Bibliographic Details
Main Authors:	Giannoccaro, M, Waters, P, Pizza, F, Liguori, R, Plazzi, G, Vincent, A
Format:	Conference item
Published:	Wiley 2017

Similar Items

Antibodies against hypocretin receptor 2 are rare in narcolepsy
by: Giannoccaro, M, et al.
Published: (2016)

Human hypocretin receptor 2 antibodies are rare in idiopathic narcolepsy
by: Giannoccaro, M, et al.
Published: (2016)

Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination
by: Thebault, S, et al.
Published: (2015)

Is narcolepsy an antibody-mediated autoimmune disease
by: Thebault, S
Published: (2012)

Narcolepsy and H1N1 vaccination: a link?
by: Thebault, S, et al.
Published: (2013)

Modelling autoimmune narcolepsy in humanised mice
by: Haris, A, et al.
Published: (2008)

Narcolepsy and excessive daytime sleepiness
by: Zeman, A, et al.
Published: (2004)

Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.
by: Siebold, C, et al.
Published: (2004)

Behaviour and neuropathology in mice injected with human contactin- associated protein 2 antibodies
by: Giannoccaro, M, et al.
Published: (2019)

The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin.
by: Stores, G, et al.
Published: (2006)

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels.
by: Liguori, R, et al.
Published: (2001)

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action
by: Barker, C, et al.
Published: (2013)

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.
by: Barker, C, et al.
Published: (2014)

Guidelines for diagnosis and therapy of MEN type 1 and type 2.
by: Brandi, M, et al.
Published: (2001)

Consensus: Guidelines for diagnosis and therapy of MEN type 1 and type 2
by: Brandi, M, et al.
Published: (2001)

Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.
by: Hale, G, et al.
Published: (2010)

Type 1 and type 2 diabetes-chalk and cheese?
by: Owen, K, et al.
Published: (2009)

Disparities in the monitoring and complication screening of people with Type 2 diabetes
by: Hinton, W, et al.
Published: (2017)

SERUM ANTIBODIES IN EPILEPSY
by: Brenner, T, et al.
Published: (2009)

The role of molecular genetics in screening for multiple endocrine neoplasia type 1.
by: Thakker, R
Published: (1994)

Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1.
by: Snowden, W, et al.
Published: (1993)

The impact of screening for Type 2 diabetes in siblings of patients with established diabetes.
by: Farmer, A, et al.
Published: (2003)

P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
by: Graus, F, et al.
Published: (2002)

Analysis of overlapping genetic association in type 1 and type 2 diabetes
by: Inshaw, JRJ, et al.
Published: (2021)

MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 - GENETIC AND BIOCHEMICAL SCREENING OF A FAMILY
by: Jansen, S, et al.
Published: (1991)

GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
by: Castleden, H, et al.
Published: (2006)

Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.
by: Parren, P, et al.
Published: (1997)

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
by: Keymeulen, B, et al.
Published: (2005)

Detection of NMDARs antibodies in encephalitis
by: Gastaldi, M, et al.
Published: (2017)

Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months.
by: Alabraba, V, et al.
Published: (2009)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism
by: Hinton, W, et al.
Published: (2020)

High frequency of antibodies to IA-2, but lower frequencies of GAD65, ZnT8 and Tspan7 antibodies, in Asian patients with Type 1 diabetes
by: Tombs, M, et al.
Published: (2018)

11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
by: Valsamakis, G, et al.
Published: (2004)

COST-EFFECTIVENESS OF RENAL SCREENING STRATEGIES AND TREATMENT OPTIONS FOR PATIENTS WITH TYPE 1 DIABETES IN THE UNITED KINGDOM
by: Lung, T, et al.
Published: (2012)

A scientific sequel to Stieg Larsson: relationship between Pandemrix--pandemic influenza vaccine--and the subsequent development of narcolepsy.
by: Fugger, L, et al.
Published: (2014)

A scientific sequel to Stieg Larsson: Relationship between Pandemrix - pandemic influenza vaccine - and the subsequent development of narcolepsy
by: Fugger, L, et al.
Published: (2014)

Antibody neutralization and viral virulence in recurring dengue virus type 2 outbreaks
by: Wong, S.S., et al.
Published: (2007)

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".
by: Parren, P, et al.
Published: (1997)

Type 1 diabetes: a relatively unknown sibling of type 2 diabetes
by: Ahmad Mahfuz, Gazali
Published: (2021)

Intuit before tuning : type-1 and type-2 fuzzy logic controllers
by: Sarabakha, Andriy, et al.
Published: (2020)